what? really??
PI-88 does NOT "just manage symptoms". It inhibits tumour growth and metastisis. There is no approved drug therapy for post-resection liver cancer; and no other drug for the disease in late stage development. More to the point, blockbusters like Avastin extend survivial by a couple of months yet manage to generate annual sale sof over USD$2 billion!! AND it is very unlikey that a total CURE for cancer will be found anytime soon.
Assuming all goes well, PI-88 should have a long "shelf life" after approval.
PI-88 is a HUGE opportunity for Progen.
what? really??PI-88 does NOT "just manage symptoms". It inhibits...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
